Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Barchart Premier: The most comprehensive method for keeping track of all your investments. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Viatris Inc (VTRS)

Viatris Inc (VTRS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 16,792,806
  • Shares Outstanding, K 1,151,770
  • Annual Sales, $ 14,739 M
  • Annual Income, $ -634,200 K
  • EBIT $ 287 M
  • EBITDA $ 3,180 M
  • 60-Month Beta 0.79
  • Price/Sales 1.22
  • Price/Cash Flow 2.81
  • Price/Book 1.09

Options Overview Details

View History
  • Implied Volatility 40.34% (+0.48%)
  • Historical Volatility 28.29%
  • IV Percentile 66%
  • IV Rank 32.01%
  • IV High 69.86% on 04/04/25
  • IV Low 26.44% on 12/23/25
  • Expected Move (DTE 12) 0.81 (5.54%)
  • Put/Call Vol Ratio 0.37
  • Today's Volume 1,020
  • Volume Avg (30-Day) 3,153
  • Put/Call OI Ratio 0.21
  • Today's Open Interest 121,364
  • Open Int (30-Day) 128,011
  • Expected Range 13.77 to 15.39

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 10 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/25
See More
  • Average Estimate 0.52
  • Number of Estimates 4
  • High Estimate 0.54
  • Low Estimate 0.51
  • Prior Year 0.54
  • Growth Rate Est. (year over year) -3.70%

Price Performance

See More
Period Period Low Period High Performance
1-Month
12.37 +17.87%
on 01/08/26
14.60 -0.14%
on 02/06/26
+2.18 (+17.58%)
since 01/06/26
3-Month
9.92 +46.98%
on 11/07/25
14.60 -0.14%
on 02/06/26
+4.47 (+44.21%)
since 11/06/25
52-Week
6.85 +112.85%
on 04/10/25
14.60 -0.14%
on 02/06/26
+3.68 (+33.76%)
since 02/06/25

Most Recent Stories

More News
3 Unprofitable Stocks with Questionable Fundamentals

3 Unprofitable Stocks with Questionable Fundamentals

SEMR : 11.81 (-0.25%)
AVAV : 257.20 (+8.58%)
VTRS : 14.58 (+1.67%)
Viatris to Report Fourth Quarter and Full Year 2025 Financial Results on February 26, 2026, and Host Investor Event on March 19, 2026

PITTSBURGH , Feb. 3, 2026 /PRNewswire/ --  Viatris Inc. (Nasdaq: VTRS), a global healthcare company, today announced it will report fourth quarter and full year 2025 financial results on Thursday,...

VTRS : 14.58 (+1.67%)
Viatris Appoints Matthew J. Maletta as Chief Legal Officer

Brian Roman to Leave the Company After More Than 20 Years of Exemplary Service; Will Remain Advisor Through Transition Period 

VTRS : 14.58 (+1.67%)
What Are Wall Street Analysts' Target Price for Viatris Stock?

Though Viatris has outpaced the broader market over the past year, Wall Street analysts maintain a cautiously optimistic outlook on the stock’s prospects.

XLV : 157.71 (+1.85%)
$SPX : 6,932.30 (+1.97%)
VTRS : 14.58 (+1.67%)
Viatris Earnings Preview: What to Expect

Viatris is set to report its fourth-quarter earnings soon, with analysts forecasting a slight decline in profits.

XLV : 157.71 (+1.85%)
$SPX : 6,932.30 (+1.97%)
VTRS : 14.58 (+1.67%)
3 Reasons to Sell VTRS and 1 Stock to Buy Instead

3 Reasons to Sell VTRS and 1 Stock to Buy Instead

VTRS : 14.58 (+1.67%)
Viatris Expands Innovative Portfolio in Cardiovascular Diseases with the Company's First Launch of Inpefa® (Sotagliflozin) for the Treatment of Heart Failure

Builds on Viatris' Scientific Leadership and Commercial Legacy in Cardiovascular Diseases

VTRS : 14.58 (+1.67%)
3 Cash-Producing Stocks with Questionable Fundamentals

3 Cash-Producing Stocks with Questionable Fundamentals

ACVA : 7.37 (+4.54%)
VTRS : 14.58 (+1.67%)
NPO : 267.57 (+4.61%)
3 Volatile Stocks We Keep Off Our Radar

3 Volatile Stocks We Keep Off Our Radar

VTRS : 14.58 (+1.67%)
AGCO : 132.57 (+6.62%)
SNBR : 11.94 (+3.92%)
Viatris Appoints Lara Ramsburg as Chief People and Corporate Affairs Officer

PITTSBURGH , Jan. 8, 2026 /PRNewswire/ --  Viatris Inc. (Nasdaq: VTRS) announced today that Lara Ramsburg has been appointed Chief People and Corporate Affairs Officer. As part of Viatris' ongoing...

VTRS : 14.58 (+1.67%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Buy and ranks in the Top 1% of all short term signal directions.

Long term indicators fully support a continuation of the trend.

Relative Strength just crossed above 80%. The market has entered extreme overbought territory.

See More Share

Business Summary

Viatris, Inc. is a global healthcare company. Its portfolio comprises more than thousand approved molecules across a wide range of key therapeutic areas, including globally recognized iconic and key brands, generic, complex generic, and biosimilar products. Branded products include EpiPen, Amitiza, Lipitor...

See More

Key Turning Points

3rd Resistance Point 15.25
2nd Resistance Point 14.93
1st Resistance Point 14.75
Last Price 14.58
1st Support Level 14.25
2nd Support Level 13.93
3rd Support Level 13.75

See More

52-Week High 14.60
Last Price 14.58
Fibonacci 61.8% 11.64
Fibonacci 50% 10.73
Fibonacci 38.2% 9.81
52-Week Low 6.85

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar